StockScan > Holders > Ra Capital Management

Ra Capital Management's Portfolio and 13F Filing

Value: $4.7B
Website:
CIK: 0001346824
Phone: 617-778-2500
Address: 200 Berkeley Street, 18th Floor, Boston, MA (02116)
Latest 13F Filing: 2026-08-14
Ra Capital Management's Stock Holdings & 13F Form
# Stock Name Symbol Current Price

Previous Holdings

(# Shares)

Current Holdings

(# Shares)

Current Value Percent
61 SAB Biotherapeutics, Inc. Common Stock SABS $2.68 N/A 4,401,500 $11,796,020 0.25%
62 Seaport Therapeutics, Inc. Common Stock SPTX $16.08 N/A 700,000 $11,256,000 0.24%
63 Palisade Bio, Inc. Common Stock PALI $1.47 N/A 7,124,116 $10,436,830 0.22%
64 Capricor Therapeutics Inc CAPR $6.88 N/A 1,507,844 $10,373,967 0.22%
65 OnKure Therapeutics, Inc. Class A Common Stock OKUR $2.35 N/A 3,998,333 $9,376,091 0.20%
66 BioAge Labs, Inc. Common Stock BIOA $5.57 N/A 1,671,648 $9,311,079 0.20%
67 MacroGenics, Inc. MGNX $3.42 N/A 1,864,176 $6,375,482 0.14%
68 Rani Therapeutics Holdings, Inc. Class A Common Stock RANI $0.73 N/A 8,500,000 $6,232,200 0.13%
69 Adicet Bio, Inc. Common Stock ACET $5.11 N/A 932,624 $4,765,709 0.10%
70 Corvus Pharmaceuticals, Inc. CRVS $9.41 N/A 450,000 $4,234,500 0.09%
71 Equillium, Inc. Common Stock EQ $1.32 N/A 3,096,336 $4,087,164 0.09%
72 Werewolf Therapeutics, Inc. Common Stock HOWL $0.99 N/A 2,387,744 $2,366,493 0.05%
73 Karyopharm Therapeutics Inc. KPTI $0.43 N/A 1,917,354 $819,477 0.02%
74 Palatin Technologies, Inc. Common Stock PTN $8.19 N/A 62,124 $508,796 0.01%